GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 135 filers reported holding GENOMIC HEALTH INC in Q3 2016. The put-call ratio across all filers is 5.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,740,000 | +4.5% | 260,273 | 0.0% | 0.07% | +15.6% |
| Q1 2016 | $6,447,000 | -29.6% | 260,273 | 0.0% | 0.06% | -3.0% |
| Q4 2015 | $9,162,000 | +66.4% | 260,273 | 0.0% | 0.07% | +144.4% |
| Q3 2015 | $5,507,000 | -23.9% | 260,273 | 0.0% | 0.03% | -18.2% |
| Q2 2015 | $7,233,000 | -9.0% | 260,273 | 0.0% | 0.03% | -17.5% |
| Q1 2015 | $7,951,000 | -4.4% | 260,273 | 0.0% | 0.04% | -21.6% |
| Q4 2014 | $8,321,000 | -67.7% | 260,273 | -71.4% | 0.05% | -70.5% |
| Q3 2014 | $25,770,000 | +3.3% | 910,273 | 0.0% | 0.17% | +10.9% |
| Q2 2014 | $24,941,000 | +4.0% | 910,273 | 0.0% | 0.16% | -38.6% |
| Q1 2014 | $23,977,000 | -10.0% | 910,273 | 0.0% | 0.25% | -20.9% |
| Q4 2013 | $26,644,000 | -4.3% | 910,273 | 0.0% | 0.32% | -7.8% |
| Q3 2013 | $27,836,000 | -3.6% | 910,273 | 0.0% | 0.35% | +2.1% |
| Q2 2013 | $28,865,000 | – | 910,273 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |